Third, we did not directly investigate the role of DNAm in alternative splicing, although such alterations have been shown to contribute to cancer progression [7], and can be modulated by interactions between DNAm and proteins such as CTCF [15], MeCP2 [14] and HP1 [37]. The gene discussed is MECP2; the disease is cancer.